Effect of inhibition of inducible nitric oxide synthase (iNOS) on the murine splenic immune response induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans lipopolysaccharide

European Journal of Oral Sciences

Volumn 116, Issue 1, 2008, Pages 31-36

  Sosroseno, W ^a,c   Musa, M ^b   Ravichandran, M ^b   Ibrahim, M F ^c   Bird, P S ^d   Seymour, G J ^e  

^a AIMST UNIVERSITY   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c SCHOOL OF PHYSICS   (Malaysia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

A. Actinomycetemcomitans; I NIL; LPS; Murine; Spleen

Indexed keywords

DRUG DERIVATIVE; ENZYME INHIBITOR; GAMMA INTERFERON; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; LYSINE; N(6) (1 IMINOETHYL)LYSINE; N(6)-(1-IMINOETHYL)LYSINE; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; IMMUNOLOGY; MOUSE; SPLEEN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LYSINE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; SPLEEN;

EID: 38049075887     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2007.00501.x     Document Type: Article

References (30)

1. MUNGRUE IN, BREDT DS, STEWART DJ, HUSAIN M. From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand 2003; 179: 123-135.
2. KRÖNCKE K-D, FEHSEL K, KOLB-BACHOFEN V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998; 113: 147-156.
3. 6-(1-Iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 1994; 37: 3886-3888.
4. EHLERS S, KUTSCH S, BENINI J, COOPER A, HAHN C, GERDES J, ORME I, MARTIN C, RIETSCHEL ET. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 1999; 98: 313-323.
5. BADN W, HEGARDT P, FELLERT MA, DARABI A, ESBJÖRNSSON M, SMITH KE, JANELIDZE S, SALFORD LG, VISSE E, SIESJÖ P. Inhibition of inducible nitric oxide synthase enhances anti-tumor immune responses in rats immunized with IFNgamma-secreting glioma cells. Scand J Immunol 2007; 65: 289-297.
6. REILLY CM, FARRELLY LW, VITI D, REDMOND ST, HUTCHINSON F, RUIZ P, MANNNING P, CONNOR J, GILKELSON GS. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 2002; 61: 839-846.
7. KENDALL HK, HAASE HR, LI H, XIAO Y, BARTOLD PM. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodontal Res 2000; 35: 194-200.
8. LAPPIN DF, KJELDSEN M, SANDER L, KINANE DF. Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 2000; 35: 369-373.
9. HIROSE M, ISHIHARA K, SAITO A, NAKAOAWA T, YAMADA S, OKUDA K. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontal 2001; 72: 590-597.
10. GASPIRC B, MASERA A, SKALERIC U. Immunolocalization of inducible nitric oxide synthase in localized juvenile periodontitis patients. Connect Tissue Res 2002; 43: 413-418.
11. BATISTA AC, SILVA TA, CHUN JH, LARA VS. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002; 8: 254-260.
12. GYURKO R, SHOJI H, BATTAGLINO RA, BOUSTANY G, GIBSON FC 3RD, GENCO CA, STASHENKO P, VAN DYKE TE. Inducible nitric oxide synthase mediates bone development and P. gingivalisinduced alveolar bone loss. Bone 2005; 36: 472-479.
13. LOHINAI Z, BENEDEK P, FEHER E, GYORFI A, ROSIVALL L, FAZEKAS A, SALZMAN AL, SZABO C. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998; 123: 353-360.
14. BLIX IJS, HELGELAND K. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774. Eur J Oral Sci 1998; 106: 576-581.
15. SOSROSENO W, HERMINAJENG E, BUDIARTI S, SUSILOWATI H. Nitric oxide production by murine spleen cells stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Anaerobe 2002; 8: 333-339.
16. SOSROSENO W, BARID I, HERMINAJENG E, SUSILOWATI H. Nitric oxide production by a murine macrophage cell line (RAW264.7) induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002; 17: 72-78.
17. 6-(1-Iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 2007; 42: 124-130.
18. G-monomethylarginine in vitro and in vivo. Eur J Pharmacol 1995; 294: 703-712.
19. HERMINAJENG E, ASMARA W, YUSWANTO A, BARID I, SOSROSENO W. Protective humoral immunity induced by surface-associated material from Actinobacillus actinomycetemcomitans in mice. Microbes Infect 2001; 3: 997-1003.
20. SLADOWSKI D, STEER SJ, CLOTHIER RH, BALLS M. An improved MTT assay. J Immunol Methods 1993; 157: 203-207.
21. BABU BR, GRIFFITH OW. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol 1998; 2: 491-500.
22. SASAKI S, MIURA T, NISHIKAWA S, YAMADA K, HIRASUE M, NAKANE A. Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect Immun 1998; 66: 1017-1022.
23. GABBAI FB, BOGGIANO C, PETER T, KHANG S, ARCHER C, GOLD DP, KELLY CJ. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J. Immunol 1997; 159: 6266-6275.
24. SNAPPER CM, PAUL WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236: 944-947.
25. KAHL KG, SCHMIDT HHHW, JUNG W, SHERMAN P, TOYKA KV, ZIELASEK J. Experimental autoimmune encephalomyelitis in mice with a targeted deletion of inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 2004; 358: 58-62.
26. TANAKA S, FAKHER M, BARBOUR SE, SCHENKEIN HA, TEW JG. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses. J Periodontal Res 2006; 41: 1-9.
27. WLUK A A, OLSZEWSKI WL. Innate and adaptive processes in the spleen. Ann Transplant 2006; 11: 22-29.
28. HERMINAJENG E, SOSROSENO W, BIRD PS, SEYMOUR GJ. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model. J Periodontal 2001; 72: 1527-1534.
29. GEMMELL E, BIRD PS, FORD PJ, ASHMAN RB, GOSLING P, HU Y, SEYMOUR GJ. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. Oral Microbiol Immunol 2004; 19: 247-251.
30. GÜLLÜ C, OZMERIC N, TOKMAN B, ELGÜN S, BALOS K. Effectiveness of scaling and root planing versus modified Widman flap on nitric oxide synthase and arginase activity in patients with chronic periodontitis. J Periodontal Res 2005; 40: 168-175.